Giving statins before percutaneous coronary intervention (PCI) lowers the risk of 30-day events compared with post-PCI initiation or no or low-dose statins in patients with acute coronary syndromes ...
PARIS, France—The treatment of patients with acute coronary syndrome with PCI via the radial artery results in a significant reduction in major bleeding and major cardiovascular events when compared ...
Patients with acute coronary syndromes (ACS) with later bleeding complications that were at least moderate in severity showed a 15-fold increased risk of dying within 30 days compared with those ...
Boston, MA - Treating acute coronary syndrome (ACS) patients who underwent PCI with high-dose statin therapy results in significantly lower rates of death and cardiovascular events compared with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Despite fewer bleeding events, 1-month ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Long-term ticagrelor monotherapy after ...
heart ecg A systematic review and meta-analysis published in the American Journal of Cardiovascular Drugs compared the safety and efficacy of prasugrel and ticagrelor in patients with acute coronary ...
ACS, which includes heart attack and unstable angina (chest pain), affects more than 1.5 million people in the United States annually, many of whom are managed with PCI. (1) In 2009, an estimated ...
Bivalirudin Superior to Heparin in ‘Real World’ Patients with ACS Undergoing PCI + Coronary Stenting
SAN FRANCISCO, CA—Use of bivalirudin alone was superior to heparin alone with respect to all-cause mortality in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary ...
MIAMI, Oct. 23, 2012 /PRNewswire/ -- Daiichi Sankyo, Inc. and Eli Lilly and Company (NYSE: LLY) today announced new results of two retrospective, observational, comparative effectiveness studies of ...
"This study suggests that the ARC-HBR and PRECISE-DAPT bleeding criteria can be used to risk stratify patients and guide the therapeutic selection to lower the bleeding risk. For instance, we found ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHILADELPHIA -- ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback